Bayer Aktiengesellschaft (ETR:BAYN – Get Free Report) traded down 1% on Thursday . The company traded as low as €28.62 ($31.80) and last traded at €28.71 ($31.90). 2,567,801 shares were traded during trading, The stock had previously closed at €29.00 ($32.22).
Bayer Aktiengesellschaft Stock Performance
The company has a market cap of $29.85 billion, a P/E ratio of -23.55, a price-to-earnings-growth ratio of 36.39 and a beta of 0.97. The company has a quick ratio of 0.72, a current ratio of 1.27 and a debt-to-equity ratio of 129.94. The stock has a 50 day moving average price of €27.53 and a two-hundred day moving average price of €27.35.
About Bayer Aktiengesellschaft
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.
Featured Stories
- Five stocks we like better than Bayer Aktiengesellschaft
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- CarMax’s Impressive Rally: What Investors Should Watch Next
- What is Put Option Volume?
- MarketBeat Week in Review – 9/23 – 9/27
- Best Stocks Under $5.00
- Wake Up to This Biotech Stock That Still Has Big Potential Upside
Receive News & Ratings for Bayer Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.
